The tissue-specific distribution of ³H-seocalcitol (EB 1089) and ³H-calcitriol in ratsKISSMEYER, Anne-Marie; NIELSEN, Jeanet Løgsted; BINDERUP, Lise et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 89-90, Num 1-5, pp 43-47, issn 0960-0760, 5 p.Conference Paper

A novel vitamin D analog with two double bonds in its side chain : A potent inducer of osteoblastic cell differentiationMAHONEN, A; JÄAPSKELÄINEN, T; MÄENPÄÄ, P. H et al.Biochemical pharmacology. 1996, Vol 51, Num 7, pp 887-892, issn 0006-2952Article

Cyclodextrin solubilization of water-insoluble drugs : calcipotriol and EB-1089LOFTSSON, T; PETERSEN, D. S.Pharmazie. 1997, Vol 52, Num 10, pp 783-785, issn 0031-7144Article

Studies on two new vitamin D analogs, EB 1089 and KH 1060 : effects on bone resorption and osteoclast recruitment in vitroWIBERG, K; LJUNGHALL, S; BINDERUP, L et al.Bone (New York, NY). 1995, Vol 17, Num 4, pp 391-395, issn 8756-3282Article

EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cellsMATHIASEN, I. S; COLSTON, K. W; BINDERUP, L et al.Journal of steroid biochemistry and molecular biology. 1993, Vol 46, Num 3, pp 365-371, issn 0960-0760Article

Metabolism of the vitamin D₃ analogue EB1089 alters receptor complex formation and reduces promoter selectivityQUACK, M; HANSEN, C. M; BINDERUP, E et al.British journal of pharmacology. 1998, Vol 125, Num 4, pp 607-614, issn 0007-1188Article

The combination of a potent vitamin D₃ analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude miceSUNDARAM, Sujatha; SEA, Andrea; FELDMAN, Stephanie et al.Clinical cancer research. 2003, Vol 9, Num 6, pp 2350-2356, issn 1078-0432, 7 p.Article

Examination of structurally selective derivatization of vitamin D₃ analogues by electrospray mass spectrometryWEISKOPF, Andrew S; VOUROS, Paul; CUNNIFF, Jack et al.Journal of mass spectrometry. 2001, Vol 36, Num 1, pp 71-78, issn 1076-5174Article

Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cellsJAMES, S. Y; MACKAY, A. G; BINDERUP, L et al.Journal of endocrinology. 1994, Vol 141, Num 3, pp 555-563, issn 0022-0795Article

EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitroJAMES, S. Y; MERCER, E; BRADY, M et al.British journal of pharmacology. 1998, Vol 125, Num 5, pp 953-962, issn 0007-1188Article

Seocalcitol (EB 1089) : A vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluationHANSEN, C. M; HAMBERG, K. J; BINDERUP, E et al.Current pharmaceutical design. 2000, Vol 6, Num 7, pp 803-828, issn 1381-6128Article

Induction of apoptosis by vitamin D₃ analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinaseWOO HYUN PARK; JAE GOO SEOL; EUN SHIL KIM et al.British journal of haematology. 2000, Vol 109, Num 3, pp 576-583, issn 0007-1048Article

Apoptosis is induced by the active metabolite of vitamin D₃and its analogue EB1089 in colorectal adenoma and carcinoma cells : Possible implications for prevention and therapyDARIO DIAZ, G; PARASKEVA, C; THOMAS, M. G et al.Cancer research (Baltimore). 2000, Vol 60, Num 8, pp 2304-2312, issn 0008-5472Article

Metabolism of the vitamin D analog EB1089 by cultured human cells : Redirection of hydroxylation site to distal carbons of the side-chainNARAYANASWAMY SHANKAR, V; DILWORTH, F. J; MAKIN, H. L. J et al.Biochemical pharmacology. 1997, Vol 53, Num 6, pp 783-793, issn 0006-2952Article

Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells : A role for insulin-like growth factor binding proteinsROZEN, F; POLLAK, M.International journal of oncology. 1999, Vol 15, Num 3, pp 589-594, issn 1019-6439Article

Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cellsXIE, S. P; JAMES, S. Y; COLSTON, K. W et al.Journal of endocrinology. 1997, Vol 154, Num 3, pp 495-504, issn 0022-0795Article

Antiestrogen potentiation of antiproliferative effects of vitamin D₃ analogues in breast cancer cellsLOVE-SCHIMENTI, C. D; GIBSON, D. F. C; RATNAM, A. V et al.Cancer research (Baltimore). 1996, Vol 56, Num 12, pp 2789-2794, issn 0008-5472Article

Inhibition of breast cancer cell growth by combined treatment with vitamin D₃ analogues and tamoxifenWIJNGAARDEN, T. V; POLS, H. A. P; BUURMAN, C. J et al.Cancer research (Baltimore). 1994, Vol 54, Num 21, pp 5711-5717, issn 0008-5472Article

The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cellsEL ABDAIMI, K; DION, N; PAPAVASILIOU, V et al.Cancer research (Baltimore). 2000, Vol 60, Num 16, pp 4412-4418, issn 0008-5472Article

A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude miceBLUTT, S. E; POLEK, T. C; STEWART, L. V et al.Cancer research (Baltimore). 2000, Vol 60, Num 4, pp 779-782, issn 0008-5472Article

The Gγ/T-15 transgenic mouse model of androgen-independent prostate cancer: Target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089PEREZ-STABLE, Carlos M; SCHWARTZ, Gary G; FARINAS, Adan et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 6, pp 555-563, issn 1055-9965Article